Talk Details · PDDS 2025

Chemo-enzymatic synthesis of bridged nucleosides

Poster · Day 3

Abstract

About this talk

Over two decades, a large number of nucleosides have been synthesized, which demonstrated potent antiviral and antitumour activities and have become cornerstones of treatment for patients with cancer or viral infections. Oligonucleotide-based antisense strategies represent a unique paradigm for the treatment of a wide variety of human diseases. In order to discover new class of nucleoside derivatives with enhanced biological activities, the modifications in the sugar moietiy have been attempted, which provide a remarkable level of control over nucleoside sugar puckering and its biological activity. Herein, we report; (a) the selective biocatalytic acetylation studies on modified 3′-azido-4′-C-hydroxymethylated sugar derivatives with an aim to develop an efficient and easy method for the synthesis of ribo-azido/amino LNA monomers and xylo-azido/amino spiro-oxetano nucleosides and (b) the selective biocatalytic deacetylation studies on modified 3′-azido-4′-C-acetoxymethylated sugar derivatives with an aim to develop an efficient and easy method for the synthesis of ribo-azido/amino spiro-oxetano nucleosides and xylo-azido/amino LNA monomers.

Speaker

About the speaker

Rajesh Kumar

Rajesh Kumar

B.R.A. Bihar University, India

View full speaker profile →

Join the PDDS 2027 delegation

Valencia · September 13–15, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.